212 related articles for article (PubMed ID: 20627626)
21. HLA class II antibodies in transfusion-related acute lung injury (TRALI). A case report.
Lydaki E; Bolonaki E; Nikoloudi E; Chalkiadakis E; Iniotaki-Theodoraki A
Transfus Apher Sci; 2005 Oct; 33(2):107-11. PubMed ID: 16115801
[TBL] [Abstract][Full Text] [Related]
22. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report.
Muro M; Rivera J; Botella C; Campillo JA; Ferrer F; Alvarez-López MR
Transfus Apher Sci; 2008 Jun; 38(3):209-12. PubMed ID: 18462996
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary pathology of rapidly fatal transfusion-related acute lung injury reveals minimal evidence of diffuse alveolar damage or alveolar granulocyte infiltration.
Danielson C; Benjamin RJ; Mangano MM; Mills CJ; Waxman DA
Transfusion; 2008 Nov; 48(11):2401-8. PubMed ID: 18673344
[TBL] [Abstract][Full Text] [Related]
24. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
[TBL] [Abstract][Full Text] [Related]
25. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
[TBL] [Abstract][Full Text] [Related]
26. A possible case of recipient anti-neutrophil and anti-human leukocyte antigen antibody-mediated fatal reverse transfusion-related acute lung injury.
Jug R; Anani W; Callum J
Transfusion; 2021 Apr; 61(4):1336-1340. PubMed ID: 33666248
[TBL] [Abstract][Full Text] [Related]
27. Transfusion-related acute lung injury.
Silliman CC; McLaughlin NJ
Blood Rev; 2006 May; 20(3):139-59. PubMed ID: 16360246
[TBL] [Abstract][Full Text] [Related]
28. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
[TBL] [Abstract][Full Text] [Related]
29. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital.
Nakagawa M; Toy P
Transfusion; 2004 Dec; 44(12):1689-94. PubMed ID: 15584981
[TBL] [Abstract][Full Text] [Related]
30. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
31. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
Maślanka K; Michur H; Zupańska B; Uhrynowska M; Nowak J
Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
[TBL] [Abstract][Full Text] [Related]
32. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary injury from transfusion-related acute lung injury.
Kopko PM; Popovsky MA
Clin Chest Med; 2004 Mar; 25(1):105-11. PubMed ID: 15062602
[TBL] [Abstract][Full Text] [Related]
34. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
[TBL] [Abstract][Full Text] [Related]
35. AABB survey of transfusion-related acute lung injury policies and practices in the United States.
Kopko P; Silva M; Shulman I; Kleinman S
Transfusion; 2007 Sep; 47(9):1679-85. PubMed ID: 17725734
[TBL] [Abstract][Full Text] [Related]
36. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
37. Transfusion-related acute lung injury (TRALI): a case report and literature review.
Donelan KJ; Anderson KA
S D Med; 2011 Mar; 64(3):85-8. PubMed ID: 21473518
[TBL] [Abstract][Full Text] [Related]
38. Transfusion-related acute lung injury: a case-control pilot study of risk factors.
Sanchez R; Bacchetti P; Toy P
Am J Clin Pathol; 2007 Jul; 128(1):128-34. PubMed ID: 17580280
[TBL] [Abstract][Full Text] [Related]
39. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma.
Sachs UJ; Kauschat D; Bein G
Transfusion; 2005 Oct; 45(10):1628-31. PubMed ID: 16181214
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of leucocyte antibodies in the Dutch donor population.
Middelburg RA; Porcelijn L; Lardy N; Briët E; Vrielink H
Vox Sang; 2011 Apr; 100(3):327-35. PubMed ID: 20946548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
